Claims-Based Frailty Index as a Measure of Dementia Severity in Medicare Claims Data.

IF 4.3 2区 医学 Q1 GERIATRICS & GERONTOLOGY Journals of Gerontology Series A-Biological Sciences and Medical Sciences Pub Date : 2023-10-28 DOI:10.1093/gerona/glad166
Chan Mi Park, Stephanie Denise M Sison, Ellen P McCarthy, Sandra Shi, Natalia Gouskova, Kueiyu Joshua Lin, Dae Hyun Kim
{"title":"Claims-Based Frailty Index as a Measure of Dementia Severity in Medicare Claims Data.","authors":"Chan Mi Park, Stephanie Denise M Sison, Ellen P McCarthy, Sandra Shi, Natalia Gouskova, Kueiyu Joshua Lin, Dae Hyun Kim","doi":"10.1093/gerona/glad166","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Dementia severity is unavailable in administrative claims data. We examined whether a claims-based frailty index (CFI) can measure dementia severity in Medicare claims.</p><p><strong>Methods: </strong>This cross-sectional study included the National Health and Aging Trends Study Round 5 participants with possible or probable dementia whose Medicare claims were available. We estimated the Functional Assessment Staging Test (FAST) scale (range: 3 [mild cognitive impairment] to 7 [severe dementia]) using information from the survey. We calculated CFI (range: 0-1, higher scores indicating greater frailty) using Medicare claims 12 months prior to the participants' interview date. We examined C-statistics to evaluate the ability of the CFI in identifying moderate-to-severe dementia (FAST stage 5-7) and determined the optimal CFI cut-point that maximized both sensitivity and specificity.</p><p><strong>Results: </strong>Of the 814 participants with possible or probable dementia and measurable CFI, 686 (72.2%) patients were ≥75 years old, 448 (50.8%) were female, and 244 (25.9%) had FAST stage 5-7. The C-statistic of CFI to identify FAST stage 5-7 was 0.78 (95% confidence interval: 0.72-0.83), with a CFI cut-point of 0.280, achieving the maximum sensitivity of 76.9% and specificity of 62.8%. Participants with CFI ≥0.280 had a higher prevalence of disability (19.4% vs 58.3%) and dementia medication use (6.0% vs 22.8%) and higher risk of mortality (10.7% vs 26.3%) and nursing home admission (4.5% vs 10.6%) over 2 years than those with CFI <0.280.</p><p><strong>Conclusions: </strong>Our study suggests that CFI can be useful in identifying moderate-to-severe dementia from administrative claims among older adults with dementia.</p>","PeriodicalId":49953,"journal":{"name":"Journals of Gerontology Series A-Biological Sciences and Medical Sciences","volume":" ","pages":"2145-2151"},"PeriodicalIF":4.3000,"publicationDate":"2023-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10613007/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journals of Gerontology Series A-Biological Sciences and Medical Sciences","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/gerona/glad166","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"GERIATRICS & GERONTOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Dementia severity is unavailable in administrative claims data. We examined whether a claims-based frailty index (CFI) can measure dementia severity in Medicare claims.

Methods: This cross-sectional study included the National Health and Aging Trends Study Round 5 participants with possible or probable dementia whose Medicare claims were available. We estimated the Functional Assessment Staging Test (FAST) scale (range: 3 [mild cognitive impairment] to 7 [severe dementia]) using information from the survey. We calculated CFI (range: 0-1, higher scores indicating greater frailty) using Medicare claims 12 months prior to the participants' interview date. We examined C-statistics to evaluate the ability of the CFI in identifying moderate-to-severe dementia (FAST stage 5-7) and determined the optimal CFI cut-point that maximized both sensitivity and specificity.

Results: Of the 814 participants with possible or probable dementia and measurable CFI, 686 (72.2%) patients were ≥75 years old, 448 (50.8%) were female, and 244 (25.9%) had FAST stage 5-7. The C-statistic of CFI to identify FAST stage 5-7 was 0.78 (95% confidence interval: 0.72-0.83), with a CFI cut-point of 0.280, achieving the maximum sensitivity of 76.9% and specificity of 62.8%. Participants with CFI ≥0.280 had a higher prevalence of disability (19.4% vs 58.3%) and dementia medication use (6.0% vs 22.8%) and higher risk of mortality (10.7% vs 26.3%) and nursing home admission (4.5% vs 10.6%) over 2 years than those with CFI <0.280.

Conclusions: Our study suggests that CFI can be useful in identifying moderate-to-severe dementia from administrative claims among older adults with dementia.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
基于索赔的虚弱指数作为衡量医疗保险索赔数据中痴呆症严重程度的指标。
背景:管理索赔数据中没有痴呆症的严重程度。我们研究了基于索赔的虚弱指数(CFI)是否可以衡量医疗保险索赔中痴呆症的严重程度。方法:这项横断面研究包括国家健康和老龄化趋势研究第5轮参与者,他们可能患有或可能患有痴呆症,并且可以获得医疗保险。我们使用调查信息估计了功能评估分期测试(FAST)量表(范围:3[轻度认知障碍]至7[重度痴呆])。在参与者面试日期前12个月,我们使用联邦医疗保险索赔计算了CFI(范围:0-1,分数越高表示身体越虚弱)。我们检查了C统计量,以评估CFI在识别中度至重度痴呆(FAST 5-7期)方面的能力,并确定了使敏感性和特异性最大化的最佳CFI分界点。结果:在814名可能或可能患有痴呆症和可测量CFI的参与者中,686名(72.2%)患者年龄≥75岁,448名(50.8%)为女性,244名(25.9%)为FAST 5-7期。识别FAST 5-7期的CFI的C统计量为0.78(95%置信区间:0.72-0.83),达到76.9%的最大灵敏度和62.8%的特异性。与CFI参与者相比,CFI≥0.280的参与者在2年内残疾(19.4%vs 58.3%)和痴呆药物使用(6.0%vs 22.8%)的患病率更高,死亡率(10.7%vs 26.3%)和疗养院入院风险(4.5%vs 10.6%)更高结论:我们的研究表明老年痴呆症患者行政索赔中的中度至重度痴呆症。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
10.00
自引率
5.90%
发文量
233
审稿时长
3-8 weeks
期刊介绍: Publishes articles representing the full range of medical sciences pertaining to aging. Appropriate areas include, but are not limited to, basic medical science, clinical epidemiology, clinical research, and health services research for professions such as medicine, dentistry, allied health sciences, and nursing. It publishes articles on research pertinent to human biology and disease.
期刊最新文献
Hypoxanthine Induces Signs of Bladder Aging With Voiding Dysfunction and Lower Urinary Tract Remodeling. Skeletal Muscle Health, Physical Performance, and Lower Urinary Tract Symptoms in Older Adults: The Study of Muscle, Mobility, and Aging. Establishment of Baseline Urinary Antimicrobial Peptide Levels by Age: A Prospective Observational Study. First Observations of a Potential Association Between Accumulation of Per- and Polyfluoroalkyl Substances in the Central Nervous System and Markers of Alzheimer's Disease. No Associations Between Glucosamine Supplementation and Dementia or Parkinson's Disease: Findings From a Large Prospective Cohort Study.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1